Close Menu
Home » NIPD Genetics Pursues Potential of Methylation Markers for Prenatal Testing, Other Applications

NIPD Genetics Pursues Potential of Methylation Markers for Prenatal Testing, Other Applications

Nov 17, 2016
|
Julia Karow
Premium

NEW YORK (GenomeWeb) – NIPD Genetics of Cyprus has been advancing research into epigenetic markers to distinguish fetal from maternal DNA, which may eventually lead to new clinical tests for prenatal screening, cancer diagnostics, and other applications. In parallel, the company has been expanding sales and applications for its current Veracity noninvasive prenatal test and plans to offer microdeletion testing next year.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

For Later in Life

Bioethicists disagree with a research team's decision to allow the return of risk results for adult-onset conditions from a newborn sequencing project, according to Reuters.

At Altitude

Alterations to particular gene may enable the Quechua of Peru to better tolerate high-altitude life, Ars Technica reports.

Another Author on the List

Nature News reports that additional South Korean researchers have included the names of children on scientific papers when they did not contribute to the work.

PLOS Papers Take on Familial Disease Risk, COPD, More

In PLOS this week: statistical approach to prioritize rare variant searches, gene expression alterations in chronic obstructive pulmonary disease, and more.

Nov
19
Featured Webinar

Digital PCR for Tag Copy Number Assessment in CRISPR-Edited Cell Lines

Sponsored by
Stilla

Fluorescent proteins or self-labeling tags are invaluable tools for studying protein dynamics in living cells using fluorescence microscopy. However, quantitative imaging requires physiological levels of expression of the target protein of interest (POI), especially when stoichiometric interactions of the POI need to be investigated.

Dec
02
Featured Webinar

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of   FLT3  and  CEBPA

Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

Dec
04
Featured Webinar

Integrating Genetic Data in Clinical Workflows: How CCPM Established a Personalized Health Framework

Sponsored by
BC Platforms

This webinar will discuss what it takes to begin realizing precision medicine in a comprehensive clinical infrastructure, with insights from the Colorado Center for Personalized Medicine (CCPM).

What's Popular?

In Molecular Diagnostics

  1. Qiagen Says It Is Fielding Acquisition Offers

  2. Employee Benefits Programs Share Early Experiences Implementing Genetic Testing

    Premium

  3. Centogene to Provide Diagnostic Testing Services for PTC Therapeutics Gene Therapy Program

  4. Qiagen Upgraded to Overweight by JP Morgan; Stock Surges on Thermo Fisher Buyout Speculation

  5. Exact Sciences Sues Johns Hopkins University for 'Improperly' Demanding Royalties

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.